openPR Logo
Press release

Corifact Market Forecast 2025-2034: Evaluating Growth Factors, Segments, and Emerging Trends

03-26-2025 06:03 AM CET | Health & Medicine

Press release from: The Business Research Company

Corifact Market

Corifact Market

Which drivers are expected to have the greatest impact on the over the corifact market's growth?
The escalating incidence of bleeding disorders is anticipated to drive the growth of the corifact market in the future. Bleeding disorders hinder the blood's effective clotting ability, causing extensive or prolonged bleeding. The upsurge in such disorders can be traced back to enhanced diagnosis, heightened awareness, progress in genetic testing, lifestyle modifications, and the incidence of chronic diseases. Corifact effectively manages bleeding disorders instigated by factor XIII deficiency as it substitutes the absent clotting factor, thereby creating stable blood clots and minimizing relentless bleeding. For example, a report issued by the World Federation of Hemophilia Report, a non-profit organization based in Canada, in October 2023 stated that, in 2022, bleeding disorders were diagnosed in 427,685 people globally. This involved 257,146 cases of hemophilia (208,957 of hemophilia A, 42,203 of Hemophilia B, and 5,986 with an unspecified type), 100,505 instances of von Willebrand disease, and 70,034 cases of other bleeding disorders. Thus, the mounting incidence of bleeding disorders is propelling the corifact market's expansion.

Get Your Corifact Market Report Here:
https://www.thebusinessresearchcompany.com/report/corifact-global-market-report

What is the future CAGR of the corifact market, and how will it impact industry expansion?
In recent years, the corifact market has reached an (HCAGR) size of XX. This market is projected to grow from $XX million in 2024 to $XX million in 2025 with a compound annual growth rate (CAGR) of XX%. Factors contributing to this growth during the historical period include a rise in the usage of factor XIII concentrates, improved awareness, enhanced automation, increased demand for extended care delivery, and the implementation of new plasma fractionation technologies.

The size of the Corifact market is predicted to witness an XX (FCAGR) increase in the upcoming years, reaching $XX million by 2029 at a compound annual growth rate (CAGR) of XX%. The growth anticipated for the forecast period is due to factors such as a rise in the incidence of bleeding disorders, enhanced awareness and early diagnosis, an increase in surgical procedures, a growing client base dependence, and the extended half-life of factor VIII. Significant trends projected for the forecast period include technological advancements, improvements in healthcare infrastructure, innovative strategies for developing recombinant therapies, progress in biotechnology, and the FDA's approval of Corifact.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20024&type=smp

Which key market segments comprise the corifact market and drive its revenue growth?
The corifact market covered in this report is segmented -

1) By Product: Human-Derived Factor XIII, Recombinant Factor XII
2) By Therapeutic Applications: Routine Prophylactic Treatment, Peri-Operative Management
3) By Distribution Channels: Hospital Pharmacies, Specialty Pharmacies, Outpatient Clinics

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20024

What regions are at the forefront of corifact market expansion?
North America was the largest region in the corifact market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the corifact market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Who are the leading players fueling growth in the corifact market?
Major companies operating in the corifact market include CSL Behring

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=20024&type=smp

What Is Covered In The Corifact Global Market Report?

•Market Size Forecast: Examine the corifact market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the corifact market for a structured understanding.
•Key Players Overview: Analyze major players in the corifact market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the corifact market.
•Segment Contributions: Evaluate how different segments drive overall growth in the corifact market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the corifact market.
•Industry Challenges: Identify potential risks and obstacles affecting the corifact market.
•Competitive Landscape: Review strategic developments in the corifact market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Corifact Market Forecast 2025-2034: Evaluating Growth Factors, Segments, and Emerging Trends here

News-ID: 3937880 • Views:

More Releases from The Business Research Company

Segment Evaluation and Major Growth Areas in the Personalized Testing and Supplements Market
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future. Market Valuation and Expansion Forecast for Personalized Testing
Top Players and Market Competition in the Skin Microbiome Industry
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry. Projected Expansion in the Skin
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market Landscape
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory. Steady Growth Expected in Upadacitinib Market Size Through 2029 The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Market
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field. Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics

All 5 Releases


More Releases for Corifact

Global Corifact Market Outlook 2025-2034: Drivers, Innovations, And Future Outlo …
The Corifact Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Corifact Market Size and Projected Growth Rate? In the recent past, the corifact market has grown at a rate of XX (HCAGR). The predictions for the market suggest an escalation from a valuation
Leading Growth Driver in the Corifact Market in 2025: Rising Prevalence Of Bleed …
How Will the Corifact Market Grow, and What Is the Projected Market Size? In recent years, the corifact market has experienced a of $XX. The market is anticipated to escalate from $XX million in 2024 to $XX million in 2025, with a compound annual growth rate (CAGR) of $XX%. This growth during the historic period is the result of the escalated use of factor XIII concentrates, heightened awareness, increased automation, demand
01-11-2019 | Health & Medicine
Fact.MR
Global Factor XIII Deficiency Treatment Market Projected to Experience Major Rev …
Factor XIII deficiency is a rare genetic blood disorder that is characterised by the deficiency of clotting factor XIII. Clotting factors are proteins that play an important role in blood clotting. Patients suffering from factor XIII deficiency are able to form clots, however, these clots are highly unstable and dissolve easily, which results in prolonged uncontrolled bleeding. The severity and symptoms of the factor XIII deficiency varies from person to
Factor XIII Deficiency Treatment Market Expansion Projected to Gain an Uptick Du …
Factor XIII deficiency is a rare genetic blood disorder that is characterised by the deficiency of clotting factor XIII. Clotting factors are proteins that play an important role in blood clotting. Patients suffering from factor XIII deficiency are able to form clots, however, these clots are highly unstable and dissolve easily, which results in prolonged uncontrolled bleeding. The severity and symptoms of the factor XIII deficiency varies from person to
08-02-2018 | Health & Medicine
Fact.MR
Global Study on Factor XIII Deficiency Treatment Market and Growth Analysis Cove …
Factor XIII deficiency is a rare genetic blood disorder that is characterised by the deficiency of clotting factor XIII. Clotting factors are proteins that play an important role in blood clotting. Patients suffering from factor XIII deficiency are able to form clots, however, these clots are highly unstable and dissolve easily, which results in prolonged uncontrolled bleeding. The severity and symptoms of the factor XIII deficiency varies from person to
Critical Care Market Expected To Grow At CAGR Of 5% Between Years 2012-2019
"The Report Critical Care Market to 2019 - Growth from Factor Concentrates, New Indications and Increasing Demand for Albumin in Asia-Pacific provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" GBI Research, the leading business intelligence provider, has released its latest research, “Critical Care Market to 2019 - Growth from Factor Concentrates, New Indications and Increasing Demand for Albumin in Asia-Pacific”. The